Michelle R Thompson, PT in Lincoln, NE - Physical Medicine & Rehabilitation

Michelle R Thompson, PT is a Physical Medicine & Rehabilitation physician based in Lincoln, Nebraska. Michelle R Thompson is licensed to practice in Nebraska (license number 805) and her current practice location is 555 S 70th St, Rm 2504, Lincoln, Nebraska. She can be reached at her office (for appointments etc.) via phone at (402) 219-7498.

NPI number for Michelle R Thompson is 1215045265 and her current mailing address is 8055 O St, Ste 300, Lincoln, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1215045265.

Contact Information

	Michelle R Thompson, PT
	555 S 70th St, Rm 2504, Lincoln, NE 68510-2462
	(402) 219-7498
	Not Available

Physician's Profile

Full Name	Michelle R Thompson
Gender	Female
Speciality	Physical Medicine & Rehabilitation
Location	555 S 70th St, Lincoln, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1215045265
Provider Enumeration Date: 08/29/2006
Last Update Date: 02/29/2008

Medical Identifiers

Medical identifiers for Michelle R Thompson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215045265	NPI	-	NPPES
02172	Other	NE	BCBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208100000X	Physical Medicine & Rehabilitation	805 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michelle R Thompson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michelle R Thompson, PT 8055 O St, Ste 300, Lincoln, NE 68510-2580 Ph: (402) 421-0896	Michelle R Thompson, PT 555 S 70th St, Rm 2504, Lincoln, NE 68510-2462 Ph: (402) 219-7498

News Archive

Arab Health conference to discuss link between vitamin D deficiency and osteoporosis

Reports from the American University of Beirut Medical Centre have concluded that The Middle East and Africa region has the highest incidence of osteoporosis in the world, while UAE-based studies from the Emirates Osteoporosis Society (EOS) across Emiratis and expatriates show that one third of people in the UAE over the age of 50 suffer from osteoporosis. The society's findings also conclude that 78% of the UAE population, most notably Emirati women, suffer from Vitamin D deficiency, which is essential for good bone health, despite the abundance of sunshine.

Vertex to enroll additional treatment arm in telaprevir/VX-222 Phase 2 clinical trial for HCV

Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

Mesh used to reinforce hernia repair provides mixed outcomes, study finds

Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term follow-up, the benefits attributable to mesh were offset in part by mesh-related complications, according to a study published online by JAMA.

Etoposide plus cisplatin remains best for limited-stage SCLC

Etoposide plus cisplatin, given alongside accelerated hyperfractionated thoracic radiotherapy, remains the gold standard regimen for patients with limited-stage small-cell lung cancer, Japanese researchers say.

Combination of cobimetinib and vemurafenib can halt progression of metastatic melanoma for one year

Data from the pivotal coBRIM Phase III study, presented by Lead Investigator Dr James Larkin today at the American Society of Clinical Oncology (ASCO) annual meeting, demonstrate that Roche's investigational MEK inhibitor cobimetinib, used in combination with BRAF inhibitor vemurafenib, typically offers people with previously untreated advanced metastatic melanoma (BRAFV600 mutation-positive unresectable or metastatic) one full year (median 12.3 months) without their disease worsening.

Physical Medicine & Rehabilitation Doctors in Lincoln, NE

Deborah M Eberspacher, MPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Rm 2504, Lincoln, NE 68510 Phone: 402-219-7498 Fax: 402-421-0945
Janell R Walker, MPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 555 S 70th St, Rm 2504, Lincoln, NE 68510 Phone: 402-219-7498
Dr. Morgan Trevor Laholt, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5401 South St, Lincoln, NE 68506 Phone: 402-413-3531 Fax: 402-413-3535
Heidi A Longe, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 555 S 70th St, Rm 2504, Lincoln, NE 68510 Phone: 402-219-7498
Julia Ann Tuttle, ATC, CSCS Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: University Of Nebraska Athletic Medicine, One Memorial Stadium, Lincoln, NE 68588 Phone: 402-472-2276 Fax: 402-472-2006
Dr. Paul L Krabbenhoft, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5401 South Street, Lincoln, NE 68506 Phone: 402-413-3531 Fax: 402-413-3535

Michelle R Thompson, PT - Physical Medicine & Rehabilitation in Lincoln, NE